摘要
许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。
关键词: 许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。 癌,癌症,miRNA-205
图形摘要
Current Cancer Drug Targets
Title:The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target
Volume: 14 Issue: 7
Author(s): Haleh Vosgha, Ali Salajegheh, Robert Anthony Smith and Alfred King-Yin Lam
Affiliation:
关键词: 许多证据表明microRNA-205(MIR-205)在正常的生理中的关键调解作用以及其在许多癌症中的异常表达。事实上,miR-205已经被证实为既是抑制肿瘤也是致癌的miRNA,通过调节不同细胞通路例如细胞存活、凋亡、血管生成和转移在肿瘤发生中扮演重要角色。作为肿瘤抑制基因, miR-205可作为细胞的增殖、迁移和侵袭的抑制剂;另一方面,作为致癌基因,miR-205促进肿瘤发生和发展;在多种类型的癌症中作用于不同靶基因实现所有这些功能。同时,miR-205也展示了其作为多种癌症治疗靶标的潜力。总的来说,miR-205在不同癌症中有重要的临床和药理相关性,并作为诊断和预后的标志物以及癌症治疗的新的分子靶标。 癌,癌症,miRNA-205
摘要: Evidences have demonstrated key mediatory roles of microRNA-205 (miR-205) in normal physiology and its aberrant expression in many cancers. Indeed, miR-205 has been identified as both a tumour suppressive and oncogenic miRNA playing crucial roles in tumourigenesis through regulating different cellular pathways such as cell survival, apoptosis, angiogenesis and metastasis. As a tumour suppressor, miR-205 acts as an inhibitor of cell proliferation, migration and invasion. On the other hand, as an oncogene, miR-205 promotes tumour initiation and development. All these functions act through different target genes in various types of cancers. Also, miR-205 displays potential as a therapeutic target for different cancers. To conclude, miR-205 has important clinical and pathological correlations in different cancers and may act as a diagnostic and prognostic marker as well as new molecular target for cancer therapy.
Export Options
About this article
Cite this article as:
Vosgha Haleh, Salajegheh Ali, Smith Anthony Robert and Lam King-Yin Alfred, The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target, Current Cancer Drug Targets 2014; 14 (7) . https://dx.doi.org/10.2174/156800961407140926105634
DOI https://dx.doi.org/10.2174/156800961407140926105634 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition The Janus Face of Cathelicidin in Tumorigenesis
Current Medicinal Chemistry Rock1 & 2 Perform Overlapping and Unique Roles in Angiogenesis and Angiosarcoma Tumor Progression
Current Molecular Medicine Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis Angiogenic Properties of Primary Cells Intended at Bone Regeneration: A Comparison to Differentiated Cells Using the CAM Assay
Current Angiogenesis (Discontinued) Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Expression of mTOR/70S6K Signaling Pathway in Melanoma Cancer Cells and the Effects of Dacarbazine and Metformin
Current Cancer Therapy Reviews Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids
Current Drug Metabolism In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery Melittin: A Natural Peptide with Expanded Therapeutic Applications
The Natural Products Journal Specific Targeting of Akt Kinase Isoforms: Taking the Precise Path for Prevention and Treatment of Cancer
Current Drug Targets Thiomers, Mucoadhesion and Oral Delivery of Biomacromolecules
Current Drug Therapy Kruppel-Like Factors 4 and 5: Unity in Diversity
Current Genomics Morphologic and Molecular Backgrounds for Personalized Management of Genito-Urinary Cancers: An Overview
Current Drug Targets Can we Consider Zoledronic Acid a New Antitumor Agent? Recent Evidence in Clinical Setting
Current Cancer Drug Targets Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings
Current Radiopharmaceuticals Unified Multi-target Approach for the Rational in silico Design of Anti-bladder Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Different Gene Therapy Strategies: A Overview for Prostate Cancer
Current Gene Therapy Could Growth Factor-Mediated Extracellular Matrix Deposition and Degradation Offer the Ground for Directed Pharmacological Targeting in Fibrosarcoma?
Current Medicinal Chemistry Statins and Alkylphospholipids as New Anticancer Agents Targeting Lipid Metabolism
Anti-Cancer Agents in Medicinal Chemistry